RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · IEX Real-Time Price · USD
3.230
-0.060 (-1.82%)
Jul 22, 2024, 11:41 AM EDT - Market open
RAPT Therapeutics Employees
RAPT Therapeutics had 131 employees as of December 31, 2023. The number of employees increased by 34 or 35.05% compared to the previous year.
Employees
131
Change (1Y)
34
Growth (1Y)
35.05%
Revenue / Employee
n/a
Profits / Employee
-$901,130
Market Cap
112.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
FONAR | 561 |
Akoya Biosciences | 330 |
Karyopharm Therapeutics | 325 |
TELA Bio | 227 |
Adagene | 174 |
Seer, Inc. | 147 |
KORU Medical Systems | 82 |
RAPT News
- 2 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga
- 2 months ago - RAPT Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients - GlobeNewsWire
- 3 months ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz
- 4 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT - PRNewsWire
- 4 months ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 5 months ago - RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Business Wire